DePuy Synthes designed TriLeap as a system of low-profile, procedure-specific titanium plates for foot and ankle surgeons. TriLeap covers a wide range of forefoot and midfoot reconstructive and trauma procedures. That includes the fixation and fusion of bones and bone fragments in adults and adolescents.
The FDA cleared the DePuy Synthes TriLeap technology in 2023.
TriLeap features contoured and conventional titanium plates. These plates can accommodate multiple screw shaft options to allow for rescue screws. It also has harmonized, color-coded instrumentation with ergonomic functionality that has ease of use features.
Dr. Michael Campbell, a board-certified orthopedic surgeon with Atlantic Orthopaedic Specialists, specializes in foot and ankle conditions. In a news release, Campbell said TriLeap “truly meets the diverse demands of the operating room” to enable better patient care.”
“With the launch of the TriLeap system, we now have a comprehensive portfolio for first ray surgery, which addresses conditions of the big toe, first toe bone, and foot and ankle reconstruction,” said Oray Boston, worldwide president, DePuy Synthes Trauma, Extremities, Craniomaxillofacial, Animal Health and Sports. “This product is key to our strategy, which is to help advance our forefoot and midfoot portfolio to get people back on their feet. It also builds on our established orthopaedics leadership and takes us further in our goal to lead in foot and ankle care.”
